Supernus Pharmaceuticals

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell SUPN and other ETFs, options, and stocks.

About SUPN

Supernus Pharmaceuticals, Inc. engages in the development and commercialization of products for the treatment of central nervous system diseases. It offers Trokendi XR, Oxtellar XR, APOKYN, XADAGO, and MYOBLOC products. 

CEO
Jack A. Khattar
CEOJack A. Khattar
Employees
674
Employees674
Headquarters
Rockville, Maryland
HeadquartersRockville, Maryland
Founded
2005
Founded2005
Employees
674
Employees674

SUPN Key Statistics

Market cap
2.53B
Market cap2.53B
Price-Earnings ratio
39.43
Price-Earnings ratio39.43
Dividend yield
Dividend yield
Average volume
653.45K
Average volume653.45K
High today
$45.58
High today$45.58
Low today
$43.54
Low today$43.54
Open price
$45.58
Open price$45.58
Volume
481.61K
Volume481.61K
52 Week high
$45.60
52 Week high$45.60
52 Week low
$29.16
52 Week low$29.16

SUPN News

TipRanks 2d
Supernus Pharmaceuticals CEO Makes Major Stock Sale!

New insider activity at Supernus Pharmaceuticals ( (SUPN) ) has taken place on August 29, 2025. Elevate Your Investing Strategy: Take advantage of TipRanks Prem...

People also own

Based on the portfolios of people who own SUPN. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.